Public Health Emergency Preparedness
This resource was part of AHRQ's Public Health Emergency Preparedness program, which was discontinued on June 30, 2011, in a realignment of Federal efforts.
This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.
Please go to www.ahrq.gov for current information.
Table 4.5. Postexposure Prophylaxis for Anthrax
| Patient |
Prophylactic Treatment |
| Adults (including pregnant women and immunocompromised people) |
Ciprofloxacin 500 mg, PO, BID × 60 days or Doxycycline 100 mg, PO, BID × 60 days |
| Children |
Ciprofloxacin 10-5 mg/kg, PO, BID × 60 days (total daily dose not to exceed 1000 mg) or Doxycycline at:
- >8 yr and >45 kg: 100 mg, PO, BID × 60 days.
- >8 yr and <45 kg: 2.2 mg/kg, PO, BID × 60 days.
- 8 yr or younger: 2.2 mg/kg, PO, BID × 60 days.
|
Notes: BID = twice a day; PO = by mouth.
Return to Document
5600 Fishers Lane Rockville, MD 20857